壬苯醇醚阴道用缓释凝胶的研制Preparation and in vitro drug release characterization of nonoxynol-9 sustained-release gel for vagina
王成伟,唐星,姚家荣
WANG Cheng-wei1; TANG Xing 1; YAO Jia-rong2 (1. School of Pharmacy;
摘要(Abstract):
目的制备壬苯醇醚阴道用缓释凝胶并优化其处方与工艺。方法采用正交试验设计 ,考察了聚卡波菲用量、卡波沫用量、pH值、甘油用量、液体石蜡用量、山嵛酸甘油酯用量及不同工艺对释放度的影响 ,与国外产品进行残差平方和、拟合度、区分因子和相似因子比较 ,确定壬苯醇醚阴道用缓释凝胶的处方工艺 ,并考察了其初步稳定性。结果优化所得处方工艺为 :聚卡波菲用量0 5 % (w) ,卡波沫用量 1% (w) ,甘油用量为 5 % (w) ,液体石蜡用量为 5 % (w) ,山嵛酸甘油酯用量为 1% (w) ,pH值为 4 5 ,选用工艺 1。 结论按优化处方工艺制得的壬苯醇醚阴道用缓释凝胶稳定 ,与国外产品比较具有相似的释放度 ,且以复合模式释放。
Objective To optimize the preparation and formulation of nonoxynol-9 suatained-release gel for vagina.Method The orthogonal design was used to screen the preparation and formulation of nonoxynol-9 sustained-release gel for vagina which took SUM,r2,difference factor and similarity factor compared with a similar product as index on the base of the influence of pH,preparation and the amount of Polycarbophil,Carbopol,glycerol,liquid paraffin and Compritol 888 ATO on drug release.Result The optimal combination of preparation and formulation is 0.5%(w) polycarbophil,1.0%(w) carbopol,5%(w) glycerol,10%(w) liquid paraffin and 1%(w) Compritol 888 ATO,pH 4.5 and preparation method 1.Conclusions The optimized preparation and formulation of nonoxynol-9 sustained-release gel for vagina has the properties of preliminarily steady and similar release with a foreign product.
关键词(KeyWords):
壬苯醇醚;凝胶剂;阴道给药系统;正交设计;释放度
nonoxynol-9; gels; vaginal drug delivery systems; orthogonal design; drug release in vitro
基金项目(Foundation):
作者(Authors):
王成伟,唐星,姚家荣
WANG Cheng-wei1; TANG Xing 1; YAO Jia-rong2 (1. School of Pharmacy;
参考文献(References):
- [1]高申,钟延强.现代药物新剂型新技术[M ].北京:人民军医出版社,2001.296-300.
- [2]Ch’ngHS ,ParkH ,KellyP ,etal.Bioadhesivepoly mersasplatformsfororalcontrolleddrugdeliveryⅡ:synthesisandevaluationofsomeswellingwater insolu blebioadhesivepolymers[J].JPharmSci,1985,74:399-405.
- [3]TamburicS ,CraigDQM .Acomparisonofdifferentinvitromethodsformeasuringmucoadhesiveperformance[J].EurJPharmBiopharm,1997,44:159-167.
- [4]梁文权.生物药剂学与药物动力学[M ].第2版.北京:人民卫生出版社,2003.223.
- [5]FDACDER .Guidanceforindustry:dissolutiontestingofimmediatereleasesolidoraldosageforms[EB/OL].Http://www.fda.gov/cder guidance/1713bp1.pdf/1998-02-16.
- [6]LeeCH ,ChienYW .Developmentandevaluationofamucoadhesivedrugdeliverysystemfordual controlleddeliveryofnonoxynol9[J].JControlledRelease,1996,39:93-103.
- [7]OwenDH ,PetersJJ ,KatzDF .Rheologicalpropertiesofcontraceptive gels[J].Contraception,2000,62:321-326.
- [8]DunmireErik,PlenysAM ,KatzDF .Spectropho tometricanalysisofmoleculartransingels[J].JCon trolledRelease,1999,57:127-140.
- [9]D’CruzOJ ,UckunFM .Gel microemulsionasvaginalspermicidesandintravaginaldrugdeliveryvehicles[J].Contraception,2001,64:113-123.
- [10]徐晖,丁平田,郑俊民.聚合物系统中药物的非扩散控制释放[J].药学学报,2000,35(9):710-714.
- 壬苯醇醚
- 凝胶剂
- 阴道给药系统
- 正交设计
- 释放度
nonoxynol-9 - gels
- vaginal drug delivery systems
- orthogonal design
- drug release in vitro